Search

Your search keyword '"Chen, Hua-Jun"' showing total 738 results

Search Constraints

Start Over You searched for: Author "Chen, Hua-Jun" Remove constraint Author: "Chen, Hua-Jun"
738 results on '"Chen, Hua-Jun"'

Search Results

6. Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC

7. First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial

10. Allelic Context of EGFR C797X–Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical Outcomes

11. PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial

12. Triple electromagnetically induced transparency generated slow light for multiple carbon nanotube resonators.

16. Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial

19. Controllable Fano resonance and fast to slow light in a hybrid semiconductor/superconductor ring device mediated by Majorana fermions

30. Tunable multiband directional electromagnetic scattering from spoof Mie resonant structure

35. Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets

36. Slow light in loop-coupled multimode optomechanical system.

45. Robust Majorana signature detection with a coupled quantum dot-nanomechanical resonator in all-optical domain

47. Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients: a comparative real-world study

49. PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): a phase 2, randomized, controlled trial

50. Allelic Context of EGFR C797X–Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical Outcomes

Catalog

Books, media, physical & digital resources